Morgan Stanley Hille Vax, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Hille Vax, Inc. stock. As of the latest transaction made, Morgan Stanley holds 687,379 shares of HLVX stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

687,379

Previous 251,568 173.24%

Holding current value

$1.29 Million

Previous $442,000 217.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.72 - $2.06 $749,594 - $897,770	435,811 Added 173.24%	687,379 $1.4 Million
Q3 2024 Nov 14, 2024	BUY	$1.58 - $14.42 $305,565 - $2.79 Million	193,396 Added 332.46%	251,568 $442,000
Q2 2024 Oct 17, 2024	SELL	$11.86 - $15.93 $57,651 - $77,435	-4,861 Reduced 7.71%	58,172 $841,000
Q2 2024 Aug 14, 2024	SELL	$11.86 - $15.93 $57,651 - $77,435	-4,861 Reduced 7.71%	58,172 $841,000
Q1 2024 Oct 17, 2024	BUY	$14.15 - $19.75 $68,783 - $96,004	4,861 Added 8.36%	63,033 $1.05 Million
Q1 2024 Aug 16, 2024	SELL	$14.15 - $19.75 $5.55 Million - $7.74 Million	-391,972 Reduced 86.15%	63,033 $1.05 Million
Q1 2024 May 15, 2024	SELL	$14.15 - $19.75 $5.55 Million - $7.74 Million	-391,972 Reduced 86.15%	63,033 $1.05 Million
Q4 2023 Aug 16, 2024	BUY	$10.35 - $17.11 $4.11 Million - $6.79 Million	396,833 Added 682.17%	455,005 $7.3 Million
Q4 2023 Feb 13, 2024	SELL	$10.35 - $17.11 $1.65 Million - $2.72 Million	-159,066 Reduced 25.9%	455,005 $7.3 Million
Q3 2023 Nov 15, 2023	BUY	$11.59 - $16.7 $254,296 - $366,414	21,941 Added 3.71%	614,071 $8.26 Million
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.76 $43,237 - $62,733	-3,344 Reduced 0.56%	592,130 $10.2 Million
Q1 2023 May 15, 2023	SELL	$14.73 - $18.18 $144,928 - $178,873	-9,839 Reduced 1.63%	595,474 $9.84 Million
Q4 2022 Feb 14, 2023	BUY	$13.52 - $21.46 $6.79 Million - $10.8 Million	502,197 Added 487.02%	605,313 $10.1 Million
Q3 2022 Nov 14, 2022	SELL	$10.5 - $22.01 $10,353 - $21,701	-986 Reduced 0.95%	103,116 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$8.7 - $20.18 $905,687 - $2.1 Million	104,102 New	104,102 $1.14 Million

Others Institutions Holding HLVX

# of Institutions

Shares Held

35.5M

Call Options Held

Put Options Held

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $62.5M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account